Registry for patients with Non-Alcoholic Fatty Liver Disease
Non-Alcoholic Fatty Liver Disease Patient Registry
This study is collecting information from patients with Non-Alcoholic Fatty Liver Disease to see how the condition progresses and how well different treatments work.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Health Network, Toronto Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Trial ID | NCT02298439 on ClinicalTrials.gov |
What this trial studies
The Non-Alcoholic Fatty Liver Disease (NAFLD) registry aims to gather demographic and clinical data from patients receiving treatment for NAFLD. This observational study will collect information on various factors, including patient demographics, anthropometry, nutritional intake, physical activity, and medication usage. Data will be securely stored in a password-protected database at the University Health Network in Toronto, accessible only to authorized personnel. The goal is to understand the progression of NAFLD and evaluate the effectiveness of different treatment strategies.
Who should consider this trial
Good fit: Ideal candidates for this registry are patients being treated for Non-Alcoholic Fatty Liver Disease at the Toronto General Hospital NAFLD clinic.
Not a fit: Patients not receiving treatment for NAFLD or those outside the Toronto General Hospital NAFLD clinic may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of NAFLD and improve treatment strategies for patients.
How similar studies have performed: Other studies have successfully utilized patient registries to gather data on chronic diseases, indicating potential for success with this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Patients being treated for NAFLD at the Toronto General Hospital NAFLD clinic Exclusion Criteria: * None
Where this trial is running
Toronto, Ontario
- Toronto General Hospital — Toronto, Ontario, Canada (Recruiting)
Study contacts
- Principal investigator: Johane Allard, MD, FRCPC — Uhn
- Study coordinator: Anastasia Teterina, PhD
- Email: anastasia.teterina@uhnresearch.ca
- Phone: 416-340-4104
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.